Interstitial Lung Disease

Close monitoring by a multidisciplinary team may allow pregnant women with interstitial lung disease secondary to autoimmune disease to avoid terminating their pregnancy, according to a presenter at ACR Convergence 2020 virtual meeting.

Further understanding of connective tissue disease-associated interstitial lung disease has opened doors for therapeutic options, but more work needs to be done in the field, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.

A multidisciplinary approach is key to optimizing outcomes in systemic sclerosis, given the broad range of manifestations and organ systems that may be involved, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.

Older adults with interstitial lung disease and COVID-19 have increased risk for severe disease, hospitalization and death, researchers reported in the American Journal of Respiratory and Critical Care Medicine.

In a new study, 59% of patients with connective tissue disease-related interstitial lung disease reported significant workplace productivity loss unexplained by symptoms or lung physiology.

The Healio editors have compiled a list of the most-read pulmonology news published in August.

The American Thoracic Society issued a new clinical practice guideline to aid clinicians in diagnosing hypersensitivity pneumonitis in patients with newly diagnosed interstitial lung disease — the first new guidance in 3 decades.

The Healio editors have compiled a list of recent updates in the management and treatment of pulmonary hypertension.

New analyses of the INBUILD trial show nintedanib slowed lung function decline and reduced the annual rate of FVC decline in patients with a progressive form of chronic fibrosing interstitial lung diseases, including in various subgroups.

In the IPF-PRO Registry, 50% of patients had a delay of longer than 1 year between symptom onset and diagnosis of idiopathic pulmonary fibrosis.